Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

  1. Muñoz Builes, M.
  2. Vela Cuenca, M.
  3. Fuster Soler, J.L.
  4. Astigarraga, I.
  5. Pascual Martínez, A.
  6. Vagace Valero, J.M.
  7. Tong, H.Y.
  8. Valentín Quiroga, J.
  9. Fernández Casanova, L.
  10. Escudero López, A.
  11. Sisinni, L.
  12. Blanquer, M.
  13. Mirones Aguilar, I.
  14. González Martínez, B.
  15. Borobia, A.M.
  16. Pérez-Martínez, A.
Revue:
BMJ Open

ISSN: 2044-6055

Année de publication: 2020

Volumen: 10

Número: 1

Type: Article

DOI: 10.1136/BMJOPEN-2019-029642 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus